Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDHealth Catalyst, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 5 | -$0.00 | -$0.00 | -$0.00 |
| Q2 2025 | 9 | $0.03 | $0.03 | $0.03 |
| Q3 2025 | 6 | $0.04 | $0.07 | $0.06 |
| Q4 2025 | 6 | $0.07 | $0.12 | $0.10 |
| Q1 2026 | 4 | $0.07 | $0.10 | $0.08 |
| Q2 2026 | 1 | $0.09 | $0.09 | $0.09 |
| Q3 2026 | 1 | $0.08 | $0.09 | $0.08 |
| Q4 2026 | 1 | $0.10 | $0.10 | $0.10 |
| Q1 2027 | 1 | $0.09 | $0.10 | $0.10 |
| Q2 2027 | 1 | $0.10 | $0.11 | $0.10 |
| Q3 2027 | 1 | $0.10 | $0.10 | $0.10 |
| Q4 2027 | 1 | $0.11 | $0.12 | $0.11 |
Health Catalyst, Inc. Earnings Date And Information
Health Catalyst, Inc. last posted its earnings results on Monday, November 10th, 2025. The company reported $0.06 earnings per share for the quarter, topping analysts' consensus estimates of $0.05 by $0.01. The company had revenue of 76.32 M for the quarter and had revenue of 306.58 M for the year. Health Catalyst, Inc. has generated $-1 earnings per share over the last year ($-1.15 diluted earnings per share) and currently has a price-to-earnings ratio of -1.81. Health Catalyst, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 5th, 2025 based on prior year's report dates.
Health Catalyst, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/10/2025 | Q3 2025 | $0.05 | -$0.32 | -0.37 | $75.01 M | $76.32 M |
| 08/08/2025 | Q2 2025 | N/A | -$0.59 | N/A | $80.62 M | $80.72 M |
| 05/09/2025 | Q1 2025 | N/A | -$0.35 | N/A | N/A | $79.41 M |
| 02/26/2025 | Q4 2024 | $0.11 | -$0.33 | -0.44 | N/A | $79.61 M |
| 11/06/2024 | Q3 2024 | N/A | -$0.24 | N/A | $76.27 M | $76.35 M |
| 08/07/2024 | Q2 2024 | N/A | -$0.23 | N/A | $74.96 M | $75.90 M |
| 05/09/2024 | Q1 2024 | N/A | -$0.35 | N/A | N/A | $74.72 M |
| 02/22/2024 | Q4 2023 | $0.00 | -$0.53 | -0.53 | N/A | $75.08 M |
| 11/06/2023 | Q3 2023 | N/A | -$0.39 | N/A | $73.04 M | $73.77 M |
| 08/08/2023 | Q2 2023 | N/A | -$0.58 | N/A | $72.64 M | $73.21 M |
| 05/09/2023 | Q1 2023 | N/A | -$0.60 | N/A | $71.24 M | $73.87 M |
| 02/28/2023 | Q4 2022 | -$0.10 | -$0.66 | -0.56 | $68.26 M | $69.16 M |
| 11/08/2022 | Q3 2022 | N/A | -$0.84 | N/A | $66.82 M | $68.35 M |
| 08/04/2022 | Q2 2022 | N/A | -$0.62 | N/A | $69.88 M | $70.63 M |
| 05/10/2022 | Q1 2022 | -$0.08 | -$0.42 | -0.34 | $66.01 M | $68.09 M |
| 03/01/2022 | Q4 2021 | -$0.21 | -$0.94 | -0.73 | $63.12 M | $64.72 M |
| 11/09/2021 | Q3 2021 | -$0.22 | -$0.82 | -0.6 | $60.81 M | $61.74 M |
| 08/05/2021 | Q2 2021 | N/A | -$0.80 | N/A | $56.60 M | $59.63 M |
| 05/06/2021 | Q1 2021 | N/A | -$0.65 | N/A | $54.30 M | $55.85 M |
| 02/25/2021 | Q4 2020 | -$0.18 | -$1.01 | -0.83 | $52.04 M | $53.28 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Health Catalyst, Inc. Earnings: FAQ's
Health Catalyst, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 5th, 2025 based offlast year's report dates.
In the previous quarter, Health Catalyst, Inc. (:HCAT) reported $0.06 earnings per share (EPS) to beat the analysts' consensus estimate of $0.05 by $0.01.
The conference call for Health Catalyst, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Health Catalyst, Inc.'s latest earnings report can be read online.
Health Catalyst, Inc. (:HCAT) has a recorded annual revenue of $306.58 M.
Health Catalyst, Inc. (:HCAT) has a recorded net income of $-69,502,000.Health Catalyst, Inc. has generated $-1.15 earnings per share over the last four quarters.
Health Catalyst, Inc. (:HCAT) has a price-to-earnings ratio of -1.81 and price/earnings-to-growth ratio is 0.06.